このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Hemas Holdings マネジメント

マネジメント基準チェック /24

Hemas Holdings'の CEO はRavi Jayasekeraで、 Mar2024年に任命され、の在任期間は 1 年未満です。は、会社の株式の0%を直接所有しており、その価値はLKR 10.25K 。経営陣と取締役会の平均在任期間はそれぞれ2.3年と9.5年です。

主要情報

Ravi Jayasekera

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	less than a year
CEOの所有権	0.00002%
経営陣の平均在職期間	2.3yrs
取締役会の平均在任期間	9.5yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

Ravi Jayasekera

less than a year

在職期間

Mr. Ravi Jayasekera is Chief People Officer and Member of Management Board at Hemas Holdings PLC and serves as its Acting CEO since March 31, 2024. Mr. Jayasekera was Vice President of Human Resources of U...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Ravi Jayasekera	Acting CEO	less than a year	データなし	0.000020% LKR 10.1k
Moiz Rehmanjee	Group Chief Financial Officer	1.4yrs	データなし	データなし
Manamalabaduge Saman Fernando	MD of Hemas Pharm Pvt. Ltd. and Hemas Surgical & Diagnostics Pvt. Ltd. & Member of Mgmt Board	no data	データなし	データなし
Lakith Peiris	MD of Hemas Hospitals (Private) Limited & Member of Board of Management	9.2yrs	データなし	データなし
Rakesh Khosla	MD of Srilanka	no data	データなし	データなし
Asitha F. Samaraweera	MD of Atlas Axillia Company (Private) Limited & Member of Management Board	5.6yrs	データなし	データなし
Athapaththu Mudiyanselage Dinesh Athapaththu of Kadawatha	MD of Morison Limited & Member of Management Board	3.2yrs	データなし	データなし
Sabrina Esufally	MD of Hemas Manufacturing (Private) Limited & Member of Management Board	no data	データなし	0.043% LKR 22.0m
Rizny Faisal	Chief Strategy & Growth Officer and Member of Management Board	no data	データなし	データなし
Mushin Kitchilan	Member of Management Board & Director of Hemas Transportation (Private) Limited	no data	データなし	データなし
Chulanga Perera	Group Chief Technology & Transformation Officer	less than a year	データなし	データなし
Jeewantha Sanjeewa	Chief Risk & Control Officer	no data	データなし	データなし

2.3yrs

平均在職期間

経験豊富な経営陣: HHL.N0000の経営陣は経験豊富であると考えられます ( 2.3年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Husein Esufally	Non-Executive Chairman	26.7yrs	データなし	0.78% LKR 394.1m
Kasturi Angela Wilson	Non-Executive Director	3.9yrs	データなし	データなし
Murtaza Ali Abidhusein Esufally	Non-Independent Non-Executive Director	25.8yrs	データなし	0.29% LKR 148.3m
Imtiaz Abidhusein Esufally	Non-Executive Director	33.1yrs	データなし	0.35% LKR 177.2m
Abbasally Esufally	Non-Executive Director	15.3yrs	データなし	0.42% LKR 213.7m
Jyotindra Trivedi	Independent Non-Executive Director	6.8yrs	データなし	データなし
Sumitha Anura Ekanayake	Non-Executive Independent Deputy Chairman	10.7yrs	データなし	データなし
Ranil Pathirana	Independent Non-Executive Director	1.4yrs	データなし	データなし
Amitha Amaratunga	Independent Non-Executive Director	8.4yrs	データなし	データなし
Prabhash Subasinghe	Independent Non-Executive Director	2.4yrs	データなし	データなし

9.5yrs

平均在職期間

経験豊富なボード: HHL.N0000の取締役会は経験豊富であると考えられます ( 9.5年の平均在任期間)。

Hemas Holdings マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Hemas Holdings PLC, Annual General Meeting, Jun 27, 2024

Hemas Holdings Announces Resignation of Kasturi Chellaraja, Group CEO

Hemas Holdings PLC Announces Board Appointments, Effective January 1, 2023

Hemas Holdings PLC Announces Executive Changes, Effective January 1, 2023

Hemas Holdings PLC, Annual General Meeting, Jun 28, 2022

Non-Executive Chairman recently bought LK₨180m worth of stock

Recent updates

Final dividend increased to LK₨3.00

Hemas Holdings PLC, Annual General Meeting, Jun 27, 2024

Price target decreased by 11% to LK₨97.37

Third quarter 2024 earnings released: EPS: LK₨3.72 (vs LK₨1.64 in 3Q 2023)

Second quarter 2024 earnings released: EPS: LK₨2.04 (vs LK₨1.93 in 2Q 2023)

Upcoming dividend of LK₨0.40 per share at 3.3% yield

Price target increased by 9.3% to LK₨112

Hemas Holdings Announces Resignation of Kasturi Chellaraja, Group CEO

Consensus EPS estimates fall by 17%

First quarter 2024 earnings released: EPS: LK₨1.83 (vs LK₨1.81 in 1Q 2023)

Upcoming dividend of LK₨1.95 per share at 3.4% yield

Hemas Holdings PLC (COSE:HHL.N0000) acquired remaining 24.9% stake in Atlas Axillia Co. (Pvt) Ltd from Nirmal Anrudha Madanayake for LKR 3.4 billion.

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased by 9.0% to LK₨78.50

Third quarter 2023 earnings released: EPS: LK₨1.64 (vs LK₨2.69 in 3Q 2022)

Hemas Holdings PLC Announces Board Appointments, Effective January 1, 2023

Hemas Holdings PLC Announces Executive Changes, Effective January 1, 2023

Second quarter 2023 earnings released: EPS: LK₨1.93 (vs LK₨1.58 in 2Q 2022)

Price target increased to LK₨74.25

Consensus revenue estimates increase by 11%

First quarter 2023 earnings released: EPS: LK₨1.81 (vs LK₨1.07 in 1Q 2022)

Upcoming dividend of LK₨1.95 per share

Hemas Holdings PLC, Annual General Meeting, Jun 28, 2022

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to LK₨79.08

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: EPS exceeds analyst expectations

Second quarter 2022 earnings released: EPS LK₨1.58 (vs LK₨2.33 in 2Q 2021)

Upcoming dividend of LK₨2.90 per share

Non-Executive Chairman recently bought LK₨180m worth of stock

Price target decreased to LK₨100

First quarter 2022 earnings released: EPS LK₨1.07 (vs LK₨0.45 in 1Q 2021)

Upcoming dividend of LK₨1.45 per share

Full year 2021 earnings released: EPS LK₨6.81 (vs LK₨2.07 in FY 2020)

Independent Director has left the company

New 90-day low: LK₨80.40

Third quarter 2021 earnings released: EPS LK₨2.30 (vs LK₨1.64 in 3Q 2020)

New 90-day high: LK₨105

New 90-day high: LK₨101

Eden Hotel Lanka PLC (COSE:EDEN.N0000) acquired 56.6% stake in Serendib Hotels PLC (COSE:SHOT.N0000) from Hemas Holdings PLC (COSE:HHL.N0000) for approximately LKR 790 million.

New 90-day high: LK₨90.00

Price target raised to LK₨80.90

New 90-day high: LK₨79.10

Second quarter 2021 earnings released: EPS LK₨2.16

Hemas Holdings PLC Announces Executive Changes

New 90-day high - LK₨65.10

First quarter earnings released

CEO（最高経営責任者

在職期間

リーダーシップ・チーム

平均在職期間

取締役

平均在職期間

マネジメント基準チェック /24